Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

68.25CHF
19 Jun 2019
Change (% chg)

CHF-0.25 (-0.36%)
Prev Close
CHF68.50
Open
CHF68.20
Day's High
CHF68.65
Day's Low
CHF68.05
Volume
56,884
Avg. Vol
78,377
52-wk High
CHF74.60
52-wk Low
CHF55.05

Latest Key Developments (Source: Significant Developments)

BB Biotech Q1 Profit Of CHF 890 Million
Friday, 26 Apr 2019 

April 26 (Reuters) - BB Biotech AG ::Q1 PROFIT OF CHF 890 MN (PROFIT OF CHF 28 MN IN CORRESPONDING PERIOD OF PREVIOUS YEAR).  Full Article

BB Biotech Q3 Profit Down At CHF 242 Mln
Thursday, 11 Oct 2018 

Oct 11 (Reuters) - BB Biotech AG ::FOR NINE MONTHS PERIOD ENDED SEPTEMBER 30, 2018 A PROFIT OF CHF 172 MILLION VERSUS CHF 843 MILLION YEAR AGO.IN Q3 A PROFIT OF CHF 242 MILLION (PROFIT OF CHF 365 MILLION IN CORRESPONDING PERIOD OF PREVIOUS YEAR).  Full Article

BB Biotech FY Net Result Turns to Profit Of CHF 688 Million
Friday, 16 Feb 2018 

Feb 16 (Reuters) - BB BIOTECH AG ::FY NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN IN PREVIOUS PERIOD.‍WILL PROPOSE AN ORDINARY DIVIDEND OF CHF 3.30 PER SHARE​.  Full Article

BB Biotech to propose 3.30 Sfr dividend for 2017
Friday, 19 Jan 2018 

Jan 19 (Reuters) - BB Biotech AG ::SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER.‍UNDERLYING PORTFOLIO PERFORMED WELL, ENDING YEAR UP 23.4% IN CHF, 12.5% IN EUR AND 29.2% IN USD​.‍FULL YEAR 2017 DATA SHOWED A NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN FOR FULL YEAR 2016​.‍WILL PROPOSE A RECORD REGULAR DIVIDEND OF CHF 3.30 PER SHARE AT GENERAL ASSEMBLY ON MARCH 13, 2018​.‍BELIEVES THAT 2018 WILL CONTINUE TO BRING IMPORTANT PRODUCT APPROVALS AND MILESTONES FOR SECTOR AND FOR ITS PORTFOLIO​.  Full Article

BB Biotech Q3 net profit down at CHF 365 million
Friday, 20 Oct 2017 

Oct 20 (Reuters) - BB BIOTECH AG ::PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER.Q3 ‍NET PROFIT AMOUNTED TO CHF 365 MN VERSUS PROFIT OF CHF 392 MN REPORTED IN Q3 LAST YEAR​.  Full Article

BB Biotech H1 net result turns to profit of CHF 478 mln
Friday, 21 Jul 2017 

July 21 (Reuters) - BB BIOTECH AG ::‍CONSEQUENTLY, H1 2017 NET INCOME AMOUNTED TO CHF 478 MN, COMPARED TO A LOSS OF CHF 1 170 MN FOR H1 2016​.‍Q2 NET INCOME AMOUNTED TO CHF 103 MN, COMPARED TO CHF 36 MN FOR SAME PERIOD IN 2016​.  Full Article

Photo

What's at stake for Europe Inc in a trade spat with Washington

LONDON Europe's listed companies are expected to generate 1.2 trillion euros (£1.0 trillion) in revenue from the United States this year, highlighting what's at stake as global trade tensions grow and earnings and economic growth stall.